The Swiss Stock Exchange, representing more than a third of the European life sciences market capitalization and accounting for around 35% of the total market capitalization (as of 7 April 2021), the exchange is one of Europe’s leading listing venues for biotech companies.

Location
Facts & figures
  • Type of organization
    Public company
  • Year of foundation
    2008
  • Number of employees in Switzerland
    >250
Key business
Core competencies